United States 2026 · Every advertiser
PatientsAct
This page ran 32 paid political ads on Facebook and Instagram between 29 May 2026 and 20 August 2026. Meta reports $6.9–10.5K of spend, which makes it the 4,664th largest advertiser of the 24,034 pages in our data. Advertiser type: Group or campaign. Most of its spend took no side. Race: No specific race. Paid for by PatientsACT.
Data from the Meta Ad Library, pulled 4 November 2026. Election on 3 November 2026. · Every ad of this page in Meta’s Ad Library ↗
32
ads
$8.7K
reported spend, range $6.9–10.5K
0.6%
of spend on federal races
$50
median spend per ad
Spend by week the ad started
Tone
Share of the 32 ads with text that our model classified. Attack ads name an opponent.
Most attacked
- Washington bureaucrats$4.4K
- CMS Administrator Oz$799
- Trump's Republican allies$499
Targets as the ads name them, by spend; the spellings of Donald Trump are counted together, other names as written.
Topics
Spend by race: Federal 0.6%, No specific race 99%.
Spend by ad language: English 100%.
The costliest ads
The highest-spend ad of each distinct text, as it ran.
IGSTR cuts don't hit insurance companies or hospital systems first. They hit seniors on fixed incomes, patients in rural towns with one clinic in driving distance, and the independent practices that have kept treatment accessible for years. When Medicare walks away from IGSTR reimbursement, these are the patients left with fewer options.
13 August 2026 · PatientsAct · $2–2.5K · 500K+ impressions · Attack · Ad Library
Washington bureaucrats are driving decisions that may eliminate coverage for a non-invasive cancer treatment used by Medicare patients. Many believe these choices should be made by patients and their doctors not dictated by policy. If you agree, now is the time to speak up.
3 August 2026 · PatientsAct · $900 – $999 · 250K+ impressions · Attack · Ad Library
At a time when healthcare costs are rising, Washington bureaucrats are moving to eliminate coverage for IGSRT, a non-invasive cancer treatment. That could mean fewer options and more barriers for Medicare patients who need care. Patients deserve better.
29 May 2026 · PatientsAct · $800 – $899 · 250K+ impressions · Attack · Ad Library
Even Trump allies are asking why this hasn't been fixed. Five Republican lawmakers have pushed the administration to reverse the Medicare pay cut hitting IGSTR and skin cancer care andCMS Administrator Oz has gone quiet on it. This isn't a partisan ask. It's patients waiting on an answer.
13 August 2026 · PatientsAct · $700 – $799 · 200K+ impressions · Attack · Ad Library
Nonmelanoma skin cancer is one of the most common cancers in America and IGSTR has given thousands of patients a non-surgical option. But a Medicare reimbursement cut has already pushed 160+ practices to stop offering it. That's not a policy footnote, it's patients losing access to treatment their doctor recommended.
13 August 2026 · PatientsAct · $400 – $499 · 125K+ impressions · Attack · Ad Library
Trump's Republican allies are pushing CMS to reverse a 75% cut to a skin cancer treatment. Washington bureaucrats won't listen. 160+ dermatology practices have dropped it. Result: rural seniors lose access, bureaucracy wins.
3 August 2026 · PatientsAct · $400 – $499 · 125K+ impressions · Attack · Ad Library
Figures cover domestic political ads paid in dollars, from 4 May 2026. Spend is the sum of Meta’s range midpoints; impressions above one million are reported as “1M+”, so impression figures are floors. Each ad counts in the week its delivery started, with its lifetime spend at our last pull; ads still running before the vote are counted as of 31 October 2026.
Back to the United States report, both parties and every candidate or every advertiser.